SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Space Exploration Technologies Corp., doing business as SpaceX, operates as an aerospace manufacturer, launch service provider, and satellite communications company. It is building the integrated hardware and software infrastructure of the future across space, connectivity, and AI. The firm designs, manufactures, launches, and operates products and services built on cutting-edge technologies, including the rockets and spacecraft. The company was founded by Elon Reeve Musk in 2002 and is headquartered in Starbase, TX.

Space Exploration Technologies Corp. - Ordinary Shares - Class A

SpaceX

A bullish Morgan Stanley assessment and SpaceXs proposed Florida gas pipeline to support Starship launches are fueling the rally, with traders also pointing to launch and AI-related growth prospects. Bulls celebrate the momentum and possible short covering, while skeptics question the valuation and warn about losses and upcoming share unlocks.

USA Rare Earth, Inc. is a domestic supplier of rare earth magnets and heavy rare earth elements. It develops a vertically integrated domestic supply chain for rare earth element magnet production, with a facility in Stillwater and mining rights to the Round Top heavy rare earth and critical minerals deposit in West Texas. The company was founded in May 2019 and is headquartered in Stillwater, OK.

USA Rare Earth Inc. - Ordinary Shares - Class A

USA Rare Earth Inc

USAR is drawing attention amid a prolonged selloff, with traders citing potential share-supply overhang from resale registrations and shelf filings, alongside weak rare-earth sector performance; some argue the filings are not a new share sale. The debate contrasts near-term dilution and execution concerns with the bullish long-term case for U.S. rare-earth supply-chain independence, while some traders speculate that high short interest could amplify a rebound.

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Novavax, Inc.

Novavax Inc

Novavaxs sharp rally is being tied by traders to vaccine-sector enthusiasm after Vaxcytes late-stage pneumonia-vaccine results and speculation around an unconfirmed suspected plague outbreak in Russia, alongside its partners Nuvaxovid rollout. The community is debating whether the outbreak is relevant to Novavaxwhose vaccine is not a plague vaccinewhile many also frame the move as a potential short squeeze; others caution it may be hype or a temporary spike.

Iovance Biotherapeutics, Inc. engages in the development and commercialization of cell therapies using autologous tumor-infiltrating lymphocytes (TIL) for the treatment of cancer. Its products include Amtagvi (lifileucel), and Proleukin (aldesleukin). The firm also develops investigational TIL therapies for other solid tumor cancers. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA.

Iovance Biotherapeutics Inc

Iovances raised full-year revenue outlook, reflecting stronger Amtagvi demand, has fueled a sharp re-rating and optimism about the commercial ramp. Traders are also focused on upcoming melanoma and sarcoma presentations, earnings, and NSCLC data, with debate over whether the rally can hold through potential pullbacks.

Vaxcyte, Inc. engages in the development of vaccines for infectious diseases. It focuses on conjugate vaccines and protein-based vaccines developed through the Sutro Biopharma's Xpress CF Platform, a cell-free protein synthesis technology. The company was founded by Grant E. Pickering and Jeff Fairman on November 27, 2013, and is headquartered in San Carlos, CA.

Vaxcyte Inc

Vaxcytes VAX-31 met the primary goals in a pivotal Phase 3 trial for its adult pneumococcal vaccine, with immune responses comparable to or stronger than established vaccines, driving a sharp rally. Traders are weighing the clinical win against the announced $1 billion offering and possible dilution, alongside profit-taking and volatile price action.

Emergent BioSolutions Inc. engages in the development, manufacture, and commercialization of medical countermeasures. It operates through the following segments: Commercial Product Sales, MCM Product Sales, and Services. The Commercial Product Sales segment includes NARCAN products and other commercial products that were sold as part of the travel health business. The MCM Product Sales segment focuses on the Anthrax - MCM products, Smallpox - MCM products and other products. The Services segment consists of the company’s Bioservices offerings. It offers products for civilian and military populations that address accidental, intentional, and naturally occurring public health threats. The company was founded by Fuad El-Hibri on September 5, 1998 and is headquartered in Gaithersburg, MD.

Emergent Biosolutions Inc

A suspected pneumonic plague death linked to a Russian research institute has fueled interest in Emergents biodefense portfolio and the stocks sharp move. Traders are debating whether the rally reflects renewed demand for biodefense products or short-squeeze momentum; Russian authorities have denied a lab accident.

Cardano is a blockchain platform built on academic research that enables smart contracts and decentralized applications while using significantly less energy than traditional cryptocurrencies like Bitcoin.   What sets Cardano apart is its methodical, research-driven approach — every major feature is peer-reviewed by scientists and cryptographers before being added to the network. This careful process aims to create a more secure and stable foundation compared to platforms that prioritize speed over thorough testing. The platform's native cryptocurrency, ADA, is used to send money, pay transaction fees, and participate in network governance.  Cardano uses a proof-of-stake system to process transactions, which works differently from Bitcoin's mining approach. Instead of competing to solve complex puzzles, users can "stake" their ADA — essentially locking it up temporarily — to become validators who verify transactions. The system selects validators based on how much ADA they've staked and for how long, then rewards them with additional ADA for their participation. This approach uses far less energy than traditional mining while keeping the network secure. The platform also features a two-layer design that separates basic payment transactions from smart contract operations, allowing each function to be optimized independently for better performance.   ADA holders can earn staking rewards by locking up their tokens to help secure the network, vote on proposed changes to the platform, and use ADA for international money transfers with lower fees than traditional services.  Cardano was founded in 2017 by Charles Hoskinson, who previously helped create Ethereum. Hoskinson leads Input Output Global (IOG), the technology company that builds and maintains Cardano's core software. The ecosystem operates through three organizations: IOG handles technical development, the Cardano Foundation promotes adoption and standardization, and Emurgo helps businesses integrate blockchain technology into their operations. This structure distributes responsibilities across multiple groups rather than concentrating control in a single entity.   In February 2025, major asset manager Grayscale Investments filed to create an exchange-traded fund (ETF) for Cardano with the U.S. Securities and Exchange Commission, which would allow traditional investors to buy ADA through their regular brokerage accounts without needing to set up cryptocurrency wallets.

Cardano

Cardanos rebound and perceived breakout are driving attention, with traders citing stronger volume, altcoin rotation and possible short covering. Bullish posts anticipate further gains, while skeptics warn the move may fade; some holders also point to RealFi and enterprise-partnership developments as supporting sentiment.

Wachovia Corporation, a financial holding company, provides commercial and retail banking services, and other financial services. Wachovia was a diversified financial services company based in Charlotte, North Carolina. Before its acquisition by Wells Fargo in 2008, Wachovia was the fourth-largest bank holding company in the United States based on total assets. Wachovia provided a broad range of banking, asset management, wealth management, and corporate and investment banking products and services. At its height, it was one of the largest providers of financial services in the United States, operating financial centers in 21 states and Washington, D.C., with locations from Connecticut to Florida and west to California.

Wells Fargo & Co.

Morgan Stanleys upgrade of Wells Fargo to Overweight and designation as a top pick are drawing attention, with analysts citing a clearer path to profitability improvement as the asset-cap removal takes effect. Traders are weighing that bullish outlook against concerns about net-interest-margin pressure and the banks recent weakness.

Twilio, Inc. engages in the development of communications software, cloud-based platforms, and services. It operates through Twilio Communications and Twilio Segments. The Twilio Communications segment includes the platforms Messaging and Voice. The Twilio Segment involves Segment, Engage, Flex, Email, and others. The company was founded by John Wolthuis, Jeffery G. Lawson, and Evan Cooke in March 2008 and is headquartered in San Francisco, CA.

Twilio Inc - Ordinary Shares Class A

Twilio Inc

Twilios upcoming addition to the S&P 500 is driving attention, with traders expecting index funds to buy shares as they rebalance; some see the inclusion-related demand as a near-term tailwind, while others caution that the move may invite profit-taking or be temporary. The separate debate over whether AI-agent communications will translate into meaningful Twilio revenue remains in the background.

Roundhill ETF Trust - Roundhill Memory ETF

Debate over the memory sectors supply-demand outlook is driving attention: some traders point to falling prices, Chinese production growth, and AI data-center financing risks as signs of oversupply, while others argue AI demand will keep memory tight. Frustration also centers on DRAMs perceived underperformance versus its underlying holdings.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$JPM
Share Price: $332.53

Contract Selected: Oct 30, 2026 $335 Calls

Buy Zone: $6.16 – $7.61
Target Zone: $11.31 – $13.83
Potential Upside: 73% ROI

Time to Expiration: 24 Days | Updates via https://fxcapta.com/stockinfo/

Every trade is a home run. Over 96% win rate on all trades for the past two years, over 1,000,000+ total trades. Disclaimer: The information provided on this website is for educational and informational purposes only and does not constitute financial advice. Trading involves risk, and past performance is not indicative of future results.

Fxcapta

fxcapta.com

StockTwits Web

JPMorgan Chase & Co


Share Price: $332.53

Contract Selected: Oct 30, 2026 $335 Calls

Buy Zone: $6.16 – $7.61
Target Zone: $11.31 – $13.83
Potential Upside: 73% ROI

Time to Expiration: 24 Days | Updates via 